Publications by authors named "Theo Dingermann"

Claim this Profile
U
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations.
Wallace J Brownlee, Christian Wolf, Hans-Peter Hartung, Theo Dingermann, Nadia Anshasi

Mult Scler· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Knowledge About Old Drugs: The Anti-Inflammatory Properties of Cardiac Glycosides.
Robert Fürst, Ilse Zündorf, Theo Dingermann

Planta Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Editorial: Pharmazie in unserer Zeit 6/2012].
Theo Dingermann

Pharm Unserer Zeit· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Coming soon: the pill for men?].
Ilse Zündorf, Theo Dingermann

Pharm Unserer Zeit· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[White, brown or beige rather?].
Ilse Zündorf, Theo Dingermann

Pharm Unserer Zeit· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Molecular copies of off-patent biologics that have become biosimilars: a new group recombinant products].
Theo Dingermann, Ilse Zündorf

Pharm Unserer Zeit· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do non-genomically encoded fusion transcripts cause recurrent chromosomal translocations?
Eric Kowarz, Theo Dingermann, Rolf Marschalek

Cancers (Basel)· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Premature transcript termination, trans-splicing and DNA repair: a vicious path to cancer.
Eric Kowarz, Jennifer Merkens, Michael Karas, Theo Dingermann, Rolf Marschalek

Am J Blood Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Editorial: Pharmazie in unserer Zeit 4/2012].
Theo Dingermann, Manfred Schubert-Zsilavecz, Martin Schulz

Pharm Unserer Zeit· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmazie in unserer Zeit 3/2012].
Rolf Marschalek, Theo Dingermann

Pharm Unserer Zeit· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Fitness for Couch-Potatoes? ].
Ilse Zündorf, Theo Dingermann

Pharm Unserer Zeit· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Leukemia: A highly malignant disease].
Rolf Marschalek, Ilse Zündorf, Theo Dingermann

Pharm Unserer Zeit· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Theo Dingermann, Jürgen Stein

Pharm Unserer Zeit· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Alissa Linder, Giorgio Marino, Julia Prechtel, Dorothee Rest, Floriana Sabatino, Theo Dingermann

Pharm Unserer Zeit· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Organ transplantation--from swine?].
Theo Dingermann, Ilse Zündorf

Pharm Unserer Zeit· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A complex MLL rearrangement identified five years after initial MDS diagnosis results in out-of-frame fusions without progression to acute leukemia.
Claus Meyer, Eric Kowarz, Sze-Fai Yip, Thomas Shek-Kong Wan, Tai-Kwong Chan, Theo Dingermann

Cancer Genet· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
["Demarcation issues" - an unusual subject in Pharmazie in unserer Zeit? Not at all!].
Werner Knöss, Theo Dingermann

Pharm Unserer Zeit· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[What is HUSEC041 MLST ST678?].
Thomas Winckler, Theo Dingermann, Ilse Zündorf

Pharm Unserer Zeit· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The new (threatening?) influenza pandemics].
Ilse Zündorf, Theo Dingermann

Pharm Unserer Zeit· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Editorial: Pharmazie in unserer Zeit 1/2011].
Theo Dingermann, Stefan Zeuzem

Pharm Unserer Zeit· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[SiRNA against hepatitis C?].
Ilse Zündorf, Theo Dingermann

Pharm Unserer Zeit· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Will a vaccine against hepatitis E soon be available?].
Ilse Zündorf, Theo Dingermann

Pharm Unserer Zeit· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Alfa-interferons. Genetically engineered Antivirals].
Theo Dingermann, Ilse Zündorf

Pharm Unserer Zeit· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells.
Irina Eberle, Birgit Pless, Miriam Braun, Theo Dingermann, Rolf Marschalek

Nucleic Acids Res· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[ Editorial. Pharmazie in unserer Zeit 5/2010].
Theo Dingermann, Manfred Schubert-Zsilavecz

Pharm Unserer Zeit· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis